I am working with about 400 tumour samples looking for alternative splicing in a specific gene using RNAseq. Should I be aligning the RNAseq libraries to each patient genome (so download 400 genomes), or use the one reference genome i.e. hg19? I have seen papers that use hg19 for tumour data, but was wondering for something sensitive like alternative splicing if I should go the extra mile to account for SNVs and map the reads to their personal genomes? The papers I have read about RNAseq and alternative splicing don't specify which reference genomes they use.

Similar questions and discussions